FDA approves Zyprexa for adolescents

Eli Lilly and Co. (NYSE:LLY) said FDA approved sNDAs for oral Zyprexa olanzapine to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder in patients 13-17 years of age. T...